Picture of IQ Global logo

IQG IQ Global Share Price

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Momentum

Relative Strength (%)
1m+3.67%
3m-20.76%
6m-44.85%
1yr-63.99%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w Highn/a
50d MAn/a
200d MAn/a

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capitaln/a
Return on Equityn/a
Operating Margin-322.7%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Jun 201930th Jun 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2019 / 2020

Blurred out image of IQ Global EPS forecast chart

Profile Summary

The IQ Group Global Ltd is an Australia-based life sciences and medical technology company. The Company is engaged in providing intellectual asset property management services, and integrated scientific advisory to the biopharmaceutical industry. It finds, funds and develops bioscience discoveries to create medical innovations and provide the fundamental basis for pharmaceuticals and devices that global populations of patients, hospitals and healthcare providers rely. Its platform technology, TEX Core is focused to develop compounds that are designed to be tumor localizing, well-tolerated, magnetic resonance imaging (MRI)-detectable in multiple solid tumors, including cancer cells that fail to respond to therapies. The Biosensor platform is a small, organic strip that puts accurate, timely diagnosis to patients and their primary health practitioners. The Company's platform is used for multiple diagnostic tests and translation medicine.

Directors

Last Annual
June 30th, 2018
Last Interim
June 30th, 2017
Incorporated
March 8th, 2011
Public Since
December 15th, 2011
Sector
Healthcare Providers & Services
Industry
Healthcare
Exchange
au flag iconNational Stock Exchange of Australia
Shares in Issue
156,612,032

IQG Share Price Performance

Upcoming Events for IQG

FAQ